Hikma Pharmaceuticals Company News

Epic Code:
Sub Sector:
Market Cap:

Pharmaceuticals & Biotechnology
UK Main Market
879.60928441 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Hikma Pharmaceuticals Website .

RNS News for Hikma Pharmaceuticals

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Hikma Pharmaceuticals News

Market Risers: ConvaTec Group PLC, Direct Line Insurance Group PLC, Hikma ...
DirectorsTalk Interviews - Jul 21, 2017
The stock price for ConvaTec Group PLC with EPIC code: LON:CTEC has moved up 1.75% or 5.4 points during the course of today's session so far.
Hikma Pharmaceuticals Plc (HIK) Rating Reiterated by Barclays PLC - BNB Daily (blog)
Hikma Pharmaceuticals Plc (LON:HIK) Price Target Cut to GBX 1410 by Analysts ... - Sports Perspectives

07/21/2017 12:37 PM

Market Risers: Glencore PLC, Hikma Pharmaceuticals Plc, ITV plc
DirectorsTalk Interviews - Jul 17, 2017
Stock in Hikma Pharmaceuticals Plc with ticker code: LON:HIK has moved up 1.69% or 23.36 points during the course of today's session so far.
Hikma Pharmaceuticals Plc (LON:HIK) Given “Neutral” Rating at Citigroup Inc. - Chaffey Breeze
Jefferies Group LLC Trims Hikma Pharmaceuticals Plc (LON:HIK) Target Price to ... - Stock Observer

07/17/2017 12:48 PM

Market Fallers: Hammerson plc, Hikma Pharmaceuticals Plc, InterContinental ...
DirectorsTalk Interviews - Jul 11, 2017
Shares in Hikma Pharmaceuticals Plc EPIC code: LON:HIK has slid -1.95% or -27 points in today's trading session so far.

07/11/2017 01:33 PM

Hikma Pharmaceuticals PLC (LSE:HIK): Is it now really a good time to buy?
Simply Wall St - Jul 10, 2017
Growth expectations for Hikma Pharmaceuticals PLC (LSE:HIK) are high, but many investors are starting to ask whether its last close at £14.27 can still be rationalized by the future potential.
Hikma Pharmaceuticals Plc's (LON:HIK) Neutral Rating Reaffirmed at Citigroup Inc. - Sports Perspectives

07/10/2017 08:54 AM

Market Fallers: easyJet plc, GKN plc, Hikma Pharmaceuticals Plc
DirectorsTalk Interviews - Jun 27, 2017
Shares of easyJet plc EPIC code: LON:EZJ has stepped down -1.47% or -20 points throughout the session so far. Traders did not seem confident throughout the trading session.

06/27/2017 02:07 PM

Hikma cuts revenue forecasts after drug approval setback
Financial Times - May 19, 2017
Hikma Pharmaceuticals lowered its full-year revenue forecasts in a trading update ahead of its annual general meeting today, after the most important new drug in its pipeline suffered a major setback.
Hikma's shares plunge after cutting full year revenue forecast on asthma drug ... - Proactive Investors UK
Hikma cuts revenue forecast on generic Advair delay; shares sink - Reuters

05/19/2017 07:38 AM